CLARIANE SE (CLARI.PA) Stock Fundamental Analysis
EPA:CLARI - Euronext Paris - Matif - FR0010386334 - Common Stock - Currency: EUR
CLARI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 26 industry peers in the Health Care Providers & Services industry. CLARI has a bad profitability rating. Also its financial health evaluation is rather negative. CLARI is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CLARI has reported negative net income.
CLARI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CLARI reported negative net income in multiple years.
CLARI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.39%, CLARI is doing worse than 80.77% of the companies in the same industry.
CLARI has a Return On Equity of -1.49%. This is amonst the worse of the industry: CLARI underperforms 80.77% of its industry peers.
The Return On Invested Capital of CLARI (1.86%) is worse than 73.08% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CLARI is below the industry average of 5.35%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.39% | ||
| ROE | -1.49% | ||
| ROIC | 1.86% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.98%
ROIC(5y)2.06%
1.3 Margins
CLARI has a Operating Margin (5.44%) which is comparable to the rest of the industry.
CLARI's Operating Margin has declined in the last couple of years.
CLARI has a Gross Margin of 91.68%. This is amongst the best in the industry. CLARI outperforms 96.15% of its industry peers.
In the last couple of years the Gross Margin of CLARI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.44% | ||
| PM (TTM) | N/A | ||
| GM | 91.68% |
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CLARI is destroying value.
Compared to 1 year ago, CLARI has more shares outstanding
CLARI has more shares outstanding than it did 5 years ago.
CLARI has a better debt/assets ratio than last year.
2.2 Solvency
CLARI has an Altman-Z score of 0.62. This is a bad value and indicates that CLARI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.62, CLARI is not doing good in the industry: 65.38% of the companies in the same industry are doing better.
CLARI has a debt to FCF ratio of 13.44. This is a negative value and a sign of low solvency as CLARI would need 13.44 years to pay back of all of its debts.
The Debt to FCF ratio of CLARI (13.44) is worse than 76.92% of its industry peers.
A Debt/Equity ratio of 1.78 is on the high side and indicates that CLARI has dependencies on debt financing.
The Debt to Equity ratio of CLARI (1.78) is worse than 65.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.78 | ||
| Debt/FCF | 13.44 | ||
| Altman-Z | 0.62 |
ROIC/WACC0.61
WACC3.04%
2.3 Liquidity
CLARI has a Current Ratio of 0.56. This is a bad value and indicates that CLARI is not financially healthy enough and could expect problems in meeting its short term obligations.
CLARI's Current ratio of 0.56 is on the low side compared to the rest of the industry. CLARI is outperformed by 73.08% of its industry peers.
A Quick Ratio of 0.56 indicates that CLARI may have some problems paying its short term obligations.
With a Quick ratio value of 0.56, CLARI is not doing good in the industry: 65.38% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.56 | ||
| Quick Ratio | 0.56 |
3. Growth
3.1 Past
CLARI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.18%, which is quite impressive.
Looking at the last year, CLARI shows a small growth in Revenue. The Revenue has grown by 5.73% in the last year.
Measured over the past years, CLARI shows a small growth in Revenue. The Revenue has been growing by 7.89% on average per year.
EPS 1Y (TTM)22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.24%
Revenue 1Y (TTM)5.73%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%4.4%
3.2 Future
The Earnings Per Share is expected to grow by 80.55% on average over the next years. This is a very strong growth
CLARI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.21% yearly.
EPS Next Y133.66%
EPS Next 2Y80.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.08%
Revenue Next 2Y5.05%
Revenue Next 3Y5.21%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CLARI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 45.17, which means the current valuation is very expensive for CLARI.
Based on the Price/Forward Earnings ratio, CLARI is valued a bit more expensive than the industry average as 69.23% of the companies are valued more cheaply.
CLARI's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.10.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 45.17 |
4.2 Price Multiples
CLARI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CLARI is cheaper than 69.23% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLARI indicates a rather cheap valuation: CLARI is cheaper than 96.15% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.24 | ||
| EV/EBITDA | 8.84 |
4.3 Compensation for Growth
CLARI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLARI's earnings are expected to grow with 80.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y80.55%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 10.64%, CLARI is a good candidate for dividend investing.
CLARI's Dividend Yield is rather good when compared to the industry average which is at 2.95. CLARI pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, CLARI pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
5.2 History
The dividend of CLARI decreases each year by -5.96%.
Dividend Growth(5Y)-5.96%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of CLARI are negative and hence is the payout ratio. CLARI will probably not be able to sustain this dividend level.
DP-92.12%
EPS Next 2Y80.55%
EPS Next 3YN/A
EPA:CLARI (3/7/2025, 7:00:00 PM)
3.722
-0.03 (-0.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners41.38%
Inst Owner ChangeN/A
Ins Owners5.63%
Ins Owner ChangeN/A
Market Cap1.32B
Analysts43.64
Price Target1.83 (-50.83%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
Yearly Dividend0.21
Dividend Growth(5Y)-5.96%
DP-92.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)300%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.69%
Revenue NY rev (3m)0.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 45.17 | ||
| P/S | 0.25 | ||
| P/FCF | 2.24 | ||
| P/OCF | 1.47 | ||
| P/B | 0.36 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.84 |
EPS(TTM)-0.47
EYN/A
EPS(NY)0.08
Fwd EY2.21%
FCF(TTM)1.66
FCFY44.69%
OCF(TTM)2.53
OCFY67.93%
SpS14.84
BVpS10.37
TBVpS-5.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.39% | ||
| ROE | -1.49% | ||
| ROCE | 2.53% | ||
| ROIC | 1.86% | ||
| ROICexc | 1.95% | ||
| ROICexgc | 4.01% | ||
| OM | 5.44% | ||
| PM (TTM) | N/A | ||
| GM | 91.68% | ||
| FCFM | 11.21% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.98%
ROIC(5y)2.06%
ROICexc(3y)2.1%
ROICexc(5y)2.23%
ROICexgc(3y)4.22%
ROICexgc(5y)4.56%
ROCE(3y)2.7%
ROCE(5y)2.8%
ROICexcg growth 3Y-9.02%
ROICexcg growth 5Y-8.45%
ROICexc growth 3Y-9.61%
ROICexc growth 5Y-8.51%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
F-Score5
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.78 | ||
| Debt/FCF | 13.44 | ||
| Debt/EBITDA | 6.65 | ||
| Cap/Depr | 43.77% | ||
| Cap/Sales | 5.83% | ||
| Interest Coverage | 0.96 | ||
| Cash Conversion | 90.82% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.56 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 0.62 |
F-Score5
WACC3.04%
ROIC/WACC0.61
Cap/Depr(3y)69.7%
Cap/Depr(5y)78.91%
Cap/Sales(3y)9.85%
Cap/Sales(5y)11.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.24%
EPS Next Y133.66%
EPS Next 2Y80.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.73%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%4.4%
Revenue Next Year5.08%
Revenue Next 2Y5.05%
Revenue Next 3Y5.21%
Revenue Next 5YN/A
EBIT growth 1Y-12.18%
EBIT growth 3Y-9.18%
EBIT growth 5Y-4.33%
EBIT Next Year298.99%
EBIT Next 3Y67.16%
EBIT Next 5YN/A
FCF growth 1Y85%
FCF growth 3Y23.92%
FCF growth 5Y6.15%
OCF growth 1Y11.93%
OCF growth 3Y2.33%
OCF growth 5Y3.29%